Clinical Trial Update: CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports completed Phase 1 and Phase 2 arms of a study evaluating CPI-613 in combination with a modified FOLFIRINOX regimen in locally advanced pancr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Devimistat (devimistat)
• Folinic acid (folinic acid)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: David Bajor, MD | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED